How the polio vaccine could curb coronavirus
Scientists hope the decades-old vaccination may provide protection against a second wave of Covid-19

A vaccine developed in 1952 and delivered to generations of children on lumps of sugar could become the first line of defence against Covid-19, new research suggests.
Scientists from the Global Virus Network (GVN) say the vaccination against poliomyelitis, commonly known as polio, “could provide temporary protection” from the new coronavirus.
The childhood immunisation is the second of its kind to be identified as a possible weapon against the ongoing pandemic, with large-scale trials already under way to test whether the BCG vaccine for tuberculosis could be used to tackle the health crisis.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
“If shown effective, those vaccines could potentially provide protection against the second wave of coronavirus, which is likely to crest before a covid-specific vaccine is widely available,” says The Washington Post.
The polio hypothesis
Like the BCG jab, the polio vaccine consists of a weakened - but still live - strain of the disease.
This “is expected to trigger a general immune response to any foreign organism”, during which the recipient develops antibodies to fight the specific virus or bacteria introduced into their body, says Forbes.
And such vaccines may have a useful secondary effect.
“An increasing body of evidence suggests that live attenuated vaccines can also induce broader protection against unrelated pathogens,” write researchers from the GVN, a coalition of medical virologists, in a paper published in the journal Science.
–––––––––––––––––––––––––––––––For a round-up of the most important stories from around the world - and a concise, refreshing and balanced take on the week’s news agenda - try The Week magazine. Start your trial subscription today –––––––––––––––––––––––––––––––
“A retrospective study from Denmark found that the use of OPV [oral polio vaccine] was associated with reduced hospital admissions for respiratory infections in children,” they add.
There is no evidence as yet that the polio vaccine works specifically against the new coronavirus, but the researchers are calling for immediate trials to test their theory.
Reasons for caution
Few medical interventions come without risks, and the polio vaccine is no exception.
In fact, the live oral vaccine “is actually being phased out” and replaced with an inactivated version, delivered by injection, says Dr Peter Hotez, dean of the US National School of Tropical Medicine.
This switch is partly because the live vaccine can lead to a full-blown case of polio in a small number of cases, and partly because even people who are successfully immunised will shed traces of live polio in their faeces. Once in the sewage system, the virus could enter the water supply.
“I think OPV is worth studying,” Hotez told Forbes, “but this has to be weighed against the risk of re-introducing live strains.”
Widespread vaccination has eliminated polio from all but two countries, Pakistan and Afghanistan, where the coronavirus pandemic is hampering eradication efforts. “In April, almost 40 million children missed their polio drops in Pakistan after the cancellation of the nationwide vaccination campaign,” The Guardian reports.
Most people infected with polio make a full recovery, but the virus can lead to muscle weakness, paralysis and death by suffocation in a small minority of cases.
–––––––––––––––––––––––––––––––For a round-up of the most important stories from around the world - and a concise, refreshing and balanced take on the week’s news agenda - try The Week magazine. Start your trial subscription today –––––––––––––––––––––––––––––––
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
Cherry blossom season: Washington diners’ happy time
feature The five best spots to enjoy the festivities
By The Week US Published
-
Why is the US bombing Yemen in the first place?
In the Spotlight The Trump administration's snowballing "Signalgate" scandal has helped refocus public attention onto one of the nation's least-understood military entanglements
By Rafi Schwartz, The Week US Published
-
South Korean commission exposes history of fraud and abuse in overseas adoptions
The Explainer The largest exporter of international adoptees allowed fraud to flourish, as the government pushed the adoption agenda
By Theara Coleman, The Week US Published
-
Five years on: How Covid changed everything
Feature We seem to have collectively forgotten Covid’s horrors, but they have completely reshaped politics
By The Week US Published
-
RFK Jr. offers alternative remedies as measles spreads
Speed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows
By Peter Weber, The Week US Published
-
How close are we to a norovirus vaccine?
Today's Big Question A new Moderna trial raises hopes of vanquishing a stomach bug that sickens millions a year
By David Faris Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
Israel, UN agree to Gaza pauses for polio vaccinations
Speed Read Gaza's first case of polio in 25 years was confirmed last week in a 10-month-old boy who is now partially paralyzed
By Rafi Schwartz, The Week US Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published